Concourse Financial Group Securities’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6567 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7183 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7178 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7189 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7188 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7119 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6953 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6791 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6549 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6560 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6387 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6329 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6211 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6164 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5981 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5781 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5588 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5432 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5220 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5083 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5047 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4982 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4791 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4909 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4838 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4732 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4511 |
|